Jakob Stenman
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma (NCT04903899) | Jakob Stenman | 2021-05-19 |
Track Jakob Stenman automatically
Every clearance here is in the API, with alerts when new ones post.